Resistance studies with Streptococcus pneumoniae using an in vitro dynamic model: amoxicillin versus azithromycin at clinical exposures
- 5 May 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 31 (5) , 252-260
Abstract
Current knowledge of the emergence of Streptococcus pneumoniae resistance during treatment with aminopenicillins and macrolides is limited. In particular, clinical reports on isolation of azithromycin-resistant mutants do not relate their enrichment to the actual antibiotic concentrations in blood. In the present work, the selection of amoxicillin- and azithromycin-resistant S. pneumoniae mutants at therapeutic and subtherapeutic antibiotic exposures was studied in an in vitro dynamic model. There was no enrichment of S. pneumoniae mutants resistant to amoxicillin, while azithromycin-resistant mutants were enriched in all simulations. This difference was related to the different times above the mutant prevention concentration: 60–100% of the dosing interval for amoxicillin versus zero percentage for azithromycin. These findings are in concordance with the mutant selection window hypothesis.Keywords
This publication has 42 references indexed in Scilit:
- Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 2012
- Evolution of Clonal and Susceptibility Profiles of Serotype 19A Streptococcus pneumoniae among Invasive Isolates from Children in Spain, 1990 to 2008Antimicrobial Agents and Chemotherapy, 2011
- Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical TrialPLOS Medicine, 2010
- Distribution of Serotypes, Genotypes, and Resistance Determinants among Macrolide-Resistant Streptococcus pneumoniae IsolatesAntimicrobial Agents and Chemotherapy, 2010
- Effect of Protein Binding on the Pharmacological Activity of Highly Bound AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumoniaJournal of Antimicrobial Chemotherapy, 2006
- Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimensJournal of Antimicrobial Chemotherapy, 2004
- Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic ModelAntimicrobial Agents and Chemotherapy, 2004
- Pharmacokinetic and Pharmacodynamic Parameters for Antimicrobial Effects of Cefotaxime and Amoxicillin in an In Vitro Kinetic ModelAntimicrobial Agents and Chemotherapy, 2001
- Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with LevofloxacinClinical Infectious Diseases, 2000